Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
new york top stories
4
×
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
drug prices
gene therapy
2019
activism
acute hepatic porphyria
aimmune therapeutics
allergy
ambys medicines
amicus therapeutics
ampio pharmaceuticals
What
drug
4
×
therapy
4
×
fda
approval
approved
bio
friday
gene
oral
patients
roundup
treat
advanced
agency
aimmune
allergy
alnylam’s
aren’t
atrophy
awarded
bff
conference
daily
deals
developed
developers
devoted
disease
drugs
easl
evrysdi
form
green
help
home
imminent
immunotherapy
intended
kicked
late
Language
unset
Current search:
drug
×
" new york top stories "
×
therapy
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More